BONEX Performance & Benchmarks - 15.2% in 12m
The Total Return for 3m is 13.7%, for 6m 0.3% and YTD -14.7%. Compare with Peer-Group: Biotechnology
Performance Rating
68.37%
#6 in Peer-Group
Rel. Strength
63.20%
#2822 in Stock-Universe
Total Return 12m
15.18%
#52 in Peer-Group
Total Return 5y
665.77%
#1 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 150 |
| P/E Forward | - |
| High / Low | SEK |
|---|---|
| 52 Week High | 400.20 SEK |
| 52 Week Low | 246.40 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 97.14 |
| Buy/Sell Signal +-5 | 2.02 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: BONEX (15.2%) vs XBI (-14.4%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Short Term Performance
| Symbol | 1w | 1m | 3m |
|---|---|---|---|
| BONEX | 8.49% | 21.4% | 13.7% |
| ABVX | 598% | 812% | 880% |
| ABVX | 579% | 810% | 866% |
| RGC | 1.61% | -18.5% | 1,570% |
Long Term Performance
| Symbol | 6m | 12m | 5y |
|---|---|---|---|
| BONEX | 0.29% | 15.2% | 666% |
| RGC | 0.0% | 3,851% | 4,927% |
| DRUG | 16.6% | 2,928% | 29.0% |
| ABVX | 1,089% | 491% | 502% |
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.03% | 51.7% | 101% | 23.8 | 14.3 | 0.24 | 13.8% | 4.55% |
| UTHR NASDAQ United Therapeutics |
3.55% | -11.3% | 167% | 12.1 | 11.3 | 1.43 | 78.4% | 40.1% |
| AMGN NASDAQ Amgen |
8.72% | -5.76% | 45% | 28.1 | 14.8 | 1.03 | -30.1% | 9.31% |
| NBIX NASDAQ Neurocrine Biosciences |
6.76% | -7.61% | 11.5% | 44.8 | 25.6 | 0.27 | -40.1% | 34.7% |
| BIM PA Biomerieux |
7.33% | 29.7% | -4.49% | 32.6 | 25.9 | 1.56 | -45.1% | -33.6% |
| KMDA NASDAQ Kamada |
-3.1% | 31.6% | -12.8% | 26.5 | 23.9 | 0.89 | 60.0% | 40.6% |
| PTCT NASDAQ PTC Therapeutics |
0.92% | 51.6% | 6.39% | 7.35 | 5.91 | 0.81 | - | 88.6% |
| LONN SW Lonza |
2.69% | 1.45% | 5.16% | 54.5 | 34.5 | 1.29 | 5.20% | -7.55% |
Performance Comparison: BONEX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for BONEX
| Total Return (including Dividends) | BONEX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 21.43% | 3.51% | 2.82% |
| 3 Months | 13.71% | 4.85% | 14.94% |
| 12 Months | 15.18% | -14.36% | 18.07% |
| 5 Years | 665.77% | -21.17% | 108.95% |
| Trend Stabilty (consistency of price movement) | BONEX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92.3% | 45.5% | 91.8% |
| 3 Months | 32.2% | 82.8% | 97.6% |
| 12 Months | -18.2% | -85.3% | 49.5% |
| 5 Years | 88.3% | -50.5% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | 74 %th | 17.31% | 18.10% |
| 3 Month | 61 %th | 8.46% | -1.07% |
| 12 Month | 75 %th | 34.49% | -2.45% |
| 5 Years | 100 %th | 871.42% | 266.48% |
FAQs
Does Bonesupport Holding (BONEX) outperform the market?
Yes,
over the last 12 months BONEX made 15.18%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.36%.
Over the last 3 months BONEX made 13.71%, while XBI made 4.85%.
Performance Comparison BONEX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
BONEX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.5% | 18.6% | -5.9% | -3% |
| US NASDAQ 100 | QQQ | 7.4% | 18.6% | -8.9% | -8% |
| German DAX 40 | DAX | 7.8% | 20.2% | -11.1% | -16% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 8.6% | 15.6% | -10.8% | -11% |
| Hongkong Hang Seng | HSI | 6.5% | 14.7% | -31.4% | -29% |
| India NIFTY 50 | INDA | 10.5% | 25.4% | -5.6% | 20% |
| Brasil Bovespa | EWZ | 9.4% | 28.7% | -10.2% | 12% |
BONEX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.1% | 23.7% | -4.4% | -12% |
| Consumer Discretionary | XLY | 8.9% | 18.1% | 2.6% | -7% |
| Consumer Staples | XLP | 9% | 21.2% | -3.8% | 9% |
| Energy | XLE | 4.4% | 16.6% | -0.5% | 15% |
| Financial | XLF | 8.3% | 20.6% | -3.4% | -8% |
| Health Care | XLV | 7.8% | 21.7% | 7.2% | 24% |
| Industrial | XLI | 7.3% | 17.9% | -11.3% | -8% |
| Materials | XLB | 9.9% | 18.2% | -3.1% | 14% |
| Real Estate | XLRE | 8.4% | 18.2% | -5.7% | 7% |
| Technology | XLK | 6.5% | 17.1% | -14.1% | -8% |
| Utilities | XLU | 9% | 17.9% | -11.5% | -7% |
| Aerospace & Defense | XAR | 7.4% | 18.1% | -26.2% | -33% |
| Biotech | XBI | 9.5% | 17.9% | 7.6% | 30% |
| Homebuilder | XHB | 9.7% | 14.5% | 2.9% | 25% |
| Retail | XRT | 11.4% | 17.3% | 0.1% | 10% |
BONEX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.6% | 12.3% | -2.31% | 9% |
| Natural Gas | UNG | 12.4% | 30.4% | 17.3% | 13% |
| Gold | GLD | 11.6% | 21% | -20.2% | -24% |
| Silver | SLV | 11.5% | 15.8% | -23.5% | -21% |
| Copper | CPER | 9.9% | 10.8% | -29.8% | -21% |
BONEX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.6% | 22.1% | -1.1% | 18% |
| iShares High Yield Corp. Bond | HYG | 8.5% | 21.1% | -3.6% | 6% |